-
1
-
-
84860390436
-
Ki-67 can be used for further classification of triple-negative breast cancer into two subtypes with different response and prognosis
-
10.1186/bcr2834, 21366896
-
Keam B, Im SA, Lee KH, Han SW, Oh DY, Kim JH, Lee SH, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Bang YJ. Ki-67 can be used for further classification of triple-negative breast cancer into two subtypes with different response and prognosis. Breast Cancer Res 2011, 13:R22. 10.1186/bcr2834, 21366896.
-
(2011)
Breast Cancer Res
, vol.13
-
-
Keam, B.1
Im, S.A.2
Lee, K.H.3
Han, S.W.4
Oh, D.Y.5
Kim, J.H.6
Lee, S.H.7
Han, W.8
Kim, D.W.9
Kim, T.Y.10
Park, I.A.11
Noh, D.Y.12
Heo, D.S.13
Bang, Y.J.14
-
2
-
-
0034680102
-
Molecular portraits of human breast tumours
-
10.1038/35021093, 10963602
-
Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature 2000, 406:747-752. 10.1038/35021093, 10963602.
-
(2000)
Nature
, vol.406
, pp. 747-752
-
-
Perou, C.M.1
Sorlie, T.2
Eisen, M.B.3
van de Rijn, M.4
Jeffrey, S.S.5
Rees, C.A.6
Pollack, J.R.7
Ross, D.T.8
Johnsen, H.9
Akslen, L.A.10
Fluge, O.11
Pergamenschikov, A.12
Williams, C.13
Zhu, S.X.14
Lønning, P.E.15
Børresen-Dale, A.L.16
Brown, P.O.17
Botstein, D.18
-
3
-
-
78049308800
-
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
-
10.1186/bcr2635, 20813035
-
Prat A, Parker J, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010, 12:R68. 10.1186/bcr2635, 20813035.
-
(2010)
Breast Cancer Res
, vol.12
-
-
Prat, A.1
Parker, J.2
Karginova, O.3
Fan, C.4
Livasy, C.5
Herschkowitz, J.I.6
He, X.7
Perou, C.M.8
-
4
-
-
78951482208
-
Deconstructing the molecular portraits of breast cancer
-
10.1016/j.molonc.2010.11.003, 21147047
-
Prat A, Perou CM. Deconstructing the molecular portraits of breast cancer. Mol Oncol 2011, 5:5-23. 10.1016/j.molonc.2010.11.003, 21147047.
-
(2011)
Mol Oncol
, vol.5
, pp. 5-23
-
-
Prat, A.1
Perou, C.M.2
-
5
-
-
4143150688
-
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
-
10.1158/1078-0432.CCR-04-0220, 15328174
-
Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004, 10:5367-5374. 10.1158/1078-0432.CCR-04-0220, 15328174.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 5367-5374
-
-
Nielsen, T.O.1
Hsu, F.D.2
Jensen, K.3
Cheang, M.4
Karaca, G.5
Hu, Z.6
Hernandez-Boussard, T.7
Livasy, C.8
Cowan, D.9
Dressler, L.10
Akslen, L.A.11
Ragaz, J.12
Gown, A.M.13
Gilks, C.B.14
van de Rijn, M.15
Perou, C.M.16
-
6
-
-
40949121882
-
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype
-
10.1158/1078-0432.CCR-07-1658, 18316557
-
Cheang M, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 2008, 14:1368-1376. 10.1158/1078-0432.CCR-07-1658, 18316557.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 1368-1376
-
-
Cheang, M.1
Voduc, D.2
Bajdik, C.3
Leung, S.4
McKinney, S.5
Chia, S.K.6
Perou, C.M.7
Nielsen, T.O.8
-
7
-
-
0037478605
-
Repeated observation of breast tumor subtypes in independent gene expression data sets
-
10.1073/pnas.0932692100, 166244, 12829800
-
Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lønning PE, Brown PO, Børresen-Dale AL, Botstein D. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003, 100:8418-8423. 10.1073/pnas.0932692100, 166244, 12829800.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 8418-8423
-
-
Sorlie, T.1
Tibshirani, R.2
Parker, J.3
Hastie, T.4
Marron, J.S.5
Nobel, A.6
Deng, S.7
Johnsen, H.8
Pesich, R.9
Geisler, S.10
Demeter, J.11
Perou, C.M.12
Lønning, P.E.13
Brown, P.O.14
Børresen-Dale, A.L.15
Botstein, D.16
-
8
-
-
79951962586
-
Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes?
-
10.1200/JCO.2010.28.9199, 21115855
-
Anders CK, Fan C, Parker JS, Carey LA, Blackwell KL, Klauber-DeMore N, Perou CM. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes?. J Clin Oncol 2011, 29:e18-e20. 10.1200/JCO.2010.28.9199, 21115855.
-
(2011)
J Clin Oncol
, vol.29
-
-
Anders, C.K.1
Fan, C.2
Parker, J.S.3
Carey, L.A.4
Blackwell, K.L.5
Klauber-DeMore, N.6
Perou, C.M.7
-
9
-
-
33847063053
-
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes
-
10.1158/1078-0432.CCR-06-1109, 17438091
-
Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 2007, 13:2329-2334. 10.1158/1078-0432.CCR-06-1109, 17438091.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 2329-2334
-
-
Carey, L.A.1
Dees, E.C.2
Sawyer, L.3
Gatti, L.4
Moore, D.T.5
Collichio, F.6
Ollila, D.W.7
Sartor, C.I.8
Graham, M.L.9
Perou, C.M.10
-
10
-
-
41649102048
-
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
-
10.1200/JCO.2007.14.4147, 18250347
-
Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA, Symmans WF, Gonzalez-Angulo AM, Hennessy B, Green M, Cristofanilli M, Hortobagyi GN, Pusztai L. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 2008, 26:1275-1281. 10.1200/JCO.2007.14.4147, 18250347.
-
(2008)
J Clin Oncol
, vol.26
, pp. 1275-1281
-
-
Liedtke, C.1
Mazouni, C.2
Hess, K.R.3
André, F.4
Tordai, A.5
Mejia, J.A.6
Symmans, W.F.7
Gonzalez-Angulo, A.M.8
Hennessy, B.9
Green, M.10
Cristofanilli, M.11
Hortobagyi, G.N.12
Pusztai, L.13
-
11
-
-
70249123890
-
Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer
-
10.3816/CBC.2009.s.008, 2919761, 19596646
-
Anders C, Carey L. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin Breast Cancer 2009, 9(Suppl 2):S73-S81. 10.3816/CBC.2009.s.008, 2919761, 19596646.
-
(2009)
Clin Breast Cancer
, vol.9
, Issue.SUPPL. 2
-
-
Anders, C.1
Carey, L.2
-
12
-
-
79953783229
-
The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases
-
Anders CK, Deal AM, Miller CR, Khorram C, Meng H, Burrows E, Livasy C, Fritchie K, Ewend MG, Perou CM, Carey LA. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer 2011,
-
(2011)
Cancer
-
-
Anders, C.K.1
Deal, A.M.2
Miller, C.R.3
Khorram, C.4
Meng, H.5
Burrows, E.6
Livasy, C.7
Fritchie, K.8
Ewend, M.G.9
Perou, C.M.10
Carey, L.A.11
-
13
-
-
33847063053
-
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes
-
10.1158/1078-0432.CCR-06-1109, 17438091
-
Carey L, Dees E, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 2007, 13:2329-2334. 10.1158/1078-0432.CCR-06-1109, 17438091.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 2329-2334
-
-
Carey, L.1
Dees, E.2
Sawyer, L.3
Gatti, L.4
Moore, D.T.5
Collichio, F.6
Ollila, D.W.7
Sartor, C.I.8
Graham, M.L.9
Perou, C.M.10
-
14
-
-
27244443082
-
Proliferation marker Ki-67 in early breast cancer
-
10.1200/JCO.2005.07.501, 16192605
-
Urruticoechea A, Smith I, Dowsett M. Proliferation marker Ki-67 in early breast cancer. J Clin Oncol 2005, 23:7212-7220. 10.1200/JCO.2005.07.501, 16192605.
-
(2005)
J Clin Oncol
, vol.23
, pp. 7212-7220
-
-
Urruticoechea, A.1
Smith, I.2
Dowsett, M.3
-
15
-
-
79952253747
-
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer
-
10.1158/1078-0432.CCR-10-2560, 21233401
-
Gonzalez-Angulo AM, Timms KM, Liu S, Liu S, Chen H, Litton JK, Potter J, Lanchbury JS, Stemke-Hale K, Hennessy BT, Arun BK, Hortobagyi GN, Do KA, Mills GB, Meric-Bernstam F. Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin Cancer Res 2011, 17:1082-1089. 10.1158/1078-0432.CCR-10-2560, 21233401.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 1082-1089
-
-
Gonzalez-Angulo, A.M.1
Timms, K.M.2
Liu, S.3
Liu, S.4
Chen, H.5
Litton, J.K.6
Potter, J.7
Lanchbury, J.S.8
Stemke-Hale, K.9
Hennessy, B.T.10
Arun, B.K.11
Hortobagyi, G.N.12
Do, K.A.13
Mills, G.B.14
Meric-Bernstam, F.15
-
16
-
-
0141429017
-
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
-
Foulkes WD, Stefansson IM, Chappuis PO, Bégin LR, Goffin JR, Wong N, Trudel M, Akslen LA. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 2003, 95:1482-1485.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 1482-1485
-
-
Foulkes, W.D.1
Stefansson, I.M.2
Chappuis, P.O.3
Bégin, L.R.4
Goffin, J.R.5
Wong, N.6
Trudel, M.7
Akslen, L.A.8
-
18
-
-
0035845511
-
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
-
10.1073/pnas.191367098, 58566, 11553815
-
Sorlie T, Perou C, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lønning P, Børresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874. 10.1073/pnas.191367098, 58566, 11553815.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 10869-10874
-
-
Sorlie, T.1
Perou, C.2
Tibshirani, R.3
Aas, T.4
Geisler, S.5
Johnsen, H.6
Hastie, T.7
Eisen, M.B.8
van de Rijn, M.9
Jeffrey, S.S.10
Thorsen, T.11
Quist, H.12
Matese, J.C.13
Brown, P.O.14
Botstein, D.15
Eystein Lønning, P.16
Børresen-Dale, A.L.17
-
19
-
-
77957599220
-
Poly(ADP-ribose) polymerase inhibition: targeted therapy for triple-negative breast cancer
-
10.1158/1078-0432.CCR-10-0939, 20858840
-
Anders CK, Winer EP, Ford JM, Dent R, Silver DP, Sledge GW, Carey LA. Poly(ADP-ribose) polymerase inhibition: targeted therapy for triple-negative breast cancer. Clin Cancer Res 2010, 16:4702-4710. 10.1158/1078-0432.CCR-10-0939, 20858840.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 4702-4710
-
-
Anders, C.K.1
Winer, E.P.2
Ford, J.M.3
Dent, R.4
Silver, D.P.5
Sledge, G.W.6
Carey, L.A.7
-
20
-
-
67650471685
-
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers
-
10.1056/NEJMoa0900212, 19553641
-
Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, de Bono JS. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009, 361:123-134. 10.1056/NEJMoa0900212, 19553641.
-
(2009)
N Engl J Med
, vol.361
, pp. 123-134
-
-
Fong, P.C.1
Boss, D.S.2
Yap, T.A.3
Tutt, A.4
Wu, P.5
Mergui-Roelvink, M.6
Mortimer, P.7
Swaisland, H.8
Lau, A.9
O'Connor, M.J.10
Ashworth, A.11
Carmichael, J.12
Kaye, S.B.13
Schellens, J.H.14
de Bono, J.S.15
|